Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sebastian Schneeweiss, Sc.D., M.D.

Co-Author

This page shows the publications co-authored by Sebastian Schneeweiss and Krista Huybrechts.
Connection Strength

7.347
  1. Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation. Clin Pharmacol Ther. 2020 06; 107(6):1405-1419.
    View in: PubMed
    Score: 0.920
  2. Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care. Circ Cardiovasc Qual Outcomes. 2019 02; 12(2):e005173.
    View in: PubMed
    Score: 0.860
  3. Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records. Clin Pharmacol Ther. 2019 04; 105(4):979-993.
    View in: PubMed
    Score: 0.847
  4. Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2014 Aug; 23(8):830-8.
    View in: PubMed
    Score: 0.614
  5. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e61-4.
    View in: PubMed
    Score: 0.551
  6. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012 Feb 23; 344:e977.
    View in: PubMed
    Score: 0.532
  7. Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol. 2012 Feb; 32(1):11-7.
    View in: PubMed
    Score: 0.529
  8. Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol. 2011 Nov 01; 174(9):1089-99.
    View in: PubMed
    Score: 0.516
  9. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ. 2011 Apr 19; 183(7):E411-9.
    View in: PubMed
    Score: 0.499
  10. Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data. Pharmacoepidemiol Drug Saf. 2020 09; 29(9):1151-1158.
    View in: PubMed
    Score: 0.229
  11. Evaluating utilization patterns of oral anticoagulants in routine care. J Thromb Haemost. 2019 07; 17(7):1033-1043.
    View in: PubMed
    Score: 0.220
  12. Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin. Drug Saf. 2017 02; 40(2):169-181.
    View in: PubMed
    Score: 0.187
  13. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thromb Haemost. 2015 Nov 25; 114(6):1277-89.
    View in: PubMed
    Score: 0.171
  14. Antipsychotics and mortality: adjusting for mortality risk scores to address confounding by terminal illness. J Am Geriatr Soc. 2015 Mar; 63(3):516-23.
    View in: PubMed
    Score: 0.164
  15. Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc. 2012 Mar; 60(3):420-9.
    View in: PubMed
    Score: 0.133
  16. Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study. Ann Intern Med. 2020 04 07; 172(7):463-473.
    View in: PubMed
    Score: 0.058
  17. The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force. Pharmacoepidemiol Drug Saf. 2019 12; 28(12):1640-1641.
    View in: PubMed
    Score: 0.057
  18. Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic. Epidemiology. 2018 11; 29(6):895-903.
    View in: PubMed
    Score: 0.053
  19. Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):383-390.
    View in: PubMed
    Score: 0.050
  20. Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors: A Multidatabase Observational Cohort Study. J Clin Psychopharmacol. 2017 Apr; 37(2):200-209.
    View in: PubMed
    Score: 0.047
  21. Evaluating possible confounding by prescriber in comparative effectiveness research. Epidemiology. 2015 Mar; 26(2):238-41.
    View in: PubMed
    Score: 0.041
  22. Comparative mortality risks of antipsychotic medications in community-dwelling older adults. Br J Psychiatry. 2014 Jul; 205(1):44-51.
    View in: PubMed
    Score: 0.037
  23. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 01; 174(11):1213-22.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.